Chronic obstructive pulmonary disease remains a leading cause of disability worldwide. In patients with advanced emphysema, severe static hyperinflation severely impairs respiratory mechanics and daily function. Bronchoscopic lung volume reduction using one-way valves provides a proven, minimally invasive therapeutic pathway. However, confirming endobronchial valve eligibility requires demonstrating pronounced gas trapping through physiological parameters. Standard clinical guidelines mandate a total lung capacity of at least 100 percent and a residual volume of at least 175 percent, or at least 150 percent in selected protocols, measured by whole-body plethysmography. Unfortunately, body plethysmography requires specialized equipment and trained personnel, making it inaccessible in many resource-constrained hospitals across developing nations. Consequently, many eligible candidates face unnecessary referral delays or missed therapeutic windows. Clinicians therefore need reliable surrogate methods that utilize standard pulmonary function testing and computed tomography to determine candidacy accurately.

Evaluating Endobronchial Valve Eligibility Without Plethysmography

To overcome access disparities, researchers recently evaluated whether widely available diagnostic tools could reliably predict endobronchial valve eligibility. In a notable observational investigation conducted at St. Marianna University Hospital, clinicians studied 41 patients diagnosed with chronic obstructive pulmonary disease. The investigative team compared gold-standard body plethysmography against spirometry, the helium dilution technique, and quantitative inspiratory and expiratory computed tomography scans. Furthermore, the researchers applied established mathematical formulas developed at the University of Groningen and the University of Pittsburgh to estimate gas trapping. By comparing these alternative modalities directly against plethysmographic values, investigators sought practical rule-in and rule-out cutoffs. Their systematic approach highlights how interventional pulmonologists can expand patient workups without demanding expensive plethysmographic chambers.

Diagnostic Performance of Alternative Modalities

The study demonstrated remarkable concordance between alternative physiological parameters and plethysmographic volume measurements. Specifically, inspiratory and expiratory computed tomography-derived lung volumes, helium dilution measurements, and integrated spirometric calculations correlated strongly with both residual volume and total lung capacity. Receiver operating characteristic curve analyses revealed excellent discriminative performance across all modalities. Area under the curve values for predicting endobronchial valve eligibility ranged impressively between 0.924 and 0.937. Therefore, computed tomography volumetry and helium dilution provide robust discriminative accuracy for identifying hyperinflation thresholds. These imaging metrics capture anatomical gas volumes while spirometric equations estimate physiological gas trapping. As a result, pulmonologists can confidently identify appropriate candidates using routine imaging and standard laboratory modalities.

Clinical Utility of Rule-In and Rule-Out Thresholds

A critical contribution of this research lies in establishing dual clinical thresholds for daily practice. The investigators defined a rule-out threshold that achieves 100 percent sensitivity alongside a rule-in threshold that provides 100 percent specificity. Consequently, clinicians can apply these cutoff values to stratify borderline cases efficiently. When a patient demonstrates values below the 100 percent sensitivity threshold, teams can rule out hyperinflation eligibility with absolute certainty. Conversely, patients who exceed the 100 percent specificity threshold qualify definitively for treatment without requiring confirmatory plethysmography. Furthermore, this dual-threshold approach minimizes ambiguous results. Clinicians need to refer only indeterminate individuals for advanced physiological testing. Thus, this diagnostic algorithm streamlines healthcare resource utilization and expedites essential interventions.

Implications for Pulmonology Practice in Resource-Limited Settings

These findings offer immediate practical relevance for healthcare providers operating in tiered health systems. While tertiary care institutions often house whole-body plethysmographs, district and regional medical facilities rarely possess these complex systems. Nevertheless, high-resolution computed tomography scanners and modern spirometers remain widely accessible across rural and secondary hospitals. Consequently, practicing physicians can screen emphysema patients locally rather than sending everyone for distant testing. Furthermore, earlier identification reduces disease progression and frequent acute exacerbations. Streamlined triage algorithms enable clinicians to detect severe hyperinflation sooner, facilitating timely referrals to dedicated interventional bronchoscopy centers. Ultimately, adopting these surrogate thresholds democratizes advanced respiratory care and enhances patient access to life-changing bronchoscopic interventions.

Future Directions in Emphysema Assessment

Although these results demonstrate strong diagnostic potential, several prospective validations remain necessary. First, multi-center trials with larger international cohorts must validate these cutoffs across varied ethnic demographics and physical phenotypes. Second, researchers should evaluate whether computed tomography acquisition parameters influence volumetric consistency between different imaging scanners. Additionally, incorporating automated artificial intelligence algorithms into radiology workflows could standardize volumetric quantification. Such automation will eliminate inter-observer measurement variations in everyday practice. Moreover, future studies should correlate these surrogate diagnostic thresholds directly with post-procedural functional improvements and lung collapse. As interventional bronchoscopy continues to evolve, validated non-invasive testing protocols will ensure safe, equitable, and timely patient selection globally.

Frequently Asked Questions

What are the primary criteria for endobronchial valve eligibility?

Standard guidelines require patients to exhibit significant static hyperinflation, defined as a total lung capacity of at least 100 percent and a residual volume of at least 175 percent, or 150 percent in specific protocols. Additionally, candidates must have severe airflow limitation, complete lobar fissures to prevent collateral ventilation, and persistent breathlessness despite optimal pharmacological therapy and pulmonary rehabilitation.

Why is body plethysmography considered the traditional gold standard?

Body plethysmography measures thoracic gas volume using Boyle's law, capturing both communicating and non-communicating airspaces. In severe emphysema, poorly ventilated bullae frequently trap gas that standard gas-dilution techniques fail to detect within standard measurement intervals. Therefore, plethysmography provides the most comprehensive evaluation of true residual volume and total lung capacity in obstructive airway diseases.

How can CT lung volumetry assist when plethysmography is unavailable?

Quantitative computed tomography measures total lung and air volume during maximal inspiration and expiration. These anatomical volumes correlate strongly with plethysmographic values. By applying validated mathematical formulas and specific rule-in and rule-out thresholds, clinicians can accurately confirm or exclude severe hyperinflation, allowing reliable pre-procedural triage without requiring a whole-body plethysmograph.

Disclaimer: This content is for informational and educational purposes only and should not be taken as professional medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Kinose D et al. Prediction of Total Lung Capacity and Residual Volume Eligibilities for Endobronchial Valve Treatment Using Measurements by the Helium Dilution Technique, CT-Based Lung Volume Analysis, and Spirometry. Respirology. 2026 Sep 30. doi: 10.1002/resp.70321. PMID: 42816439.
Klooster K, Slebos DJ. Endobronchial Valves for Endoscopic Lung Volume Reduction: Best Practice Recommendations from Expert Panel on Endoscopic Lung Volume Reduction. Respiration. 2017;93(2):138-146.
Criner GJ, Sue R, Wright S, et al. A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve for Severe Emphysema (LIBERATE). Am J Respir Crit Care Med. 2018;198(9):1151-1164.